参考文献/References:
[1]中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组，中华医学会神经病学分会神经血管介入协作组. 中国蛛网膜下腔出血诊治指南2019[J]. 中华神经科杂志，2019，52（12）：1006-1021.
[2]Neifert SN, Chapman EK, Martini ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade [J]. Transl Stroke Res, 2021, 12(3): 428-446.
[3]Brunet M, Chen SH, Khandelwal P, et al. Intravenous stem cell therapy for high-grade aneurysmal subarachnoid hemorrhage: case report and literature review [J]. World Neurosurg, 2019, 128: 573-575.
[4]Song Z, Zhang JH. Recent advances in stem cell research in subarachnoid hemorrhage [J]. Stem Cells Dev, 2020, 29(4): 178-186.
[5]Liu W, Li R, Yin J, et al. Mesenchymal stem cells alleviate the early brain injury of subarachnoid hemorrhage partly by suppression of Notch1-dependent neuroinflammation: involvement of Botch [J]. J Neuroinflammation, 2019, 16(1): 8.
[6]Wan Y, Song M, Xie X, et al. BMSCs regulate astrocytes through TSG-6 to protect the blood-brain barrier after sub-arachnoid hemorrhage [J]. Med Inflammation, 2021, 2021: 1-18.
[7]Ng NN, Thakor AS. Locoregional delivery of stem cell-based therapies [J]. Sci Transl Med, 2020, 12(547): a4564.
[8]Luzuriaga J, Polo Y, Pastor-Alonso O, et al. Advances and perspectives in dental pulp stem cell based neuroregeneration therapies [J]. Int J Mol Sci, 2021, 22(7): 3546.
[9]Steinbeck JA, Studer L. Moving stem cells to the clinic: potential and limitations for brain repair [J]. Neuron, 2015, 86(1): 187-206.
[10]Guo Z, Zhang L, Wu Z, et al. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model [J]. Cell Stem Cell, 2014, 14(2): 188-202.
[11]Chen T, Chen K, Chien Y, et al. Dental pulp stem cell-derived factors alleviate subarachnoid hemorrhage-induced neuroinflammation and ischemic neurological deficits [J]. Int J Mol Sci, 2019, 20(15): 3747.
[12]Nakano M, Fujimiya M. Potential effects of mesenchymal stem cell derived extracellular vesicles and exosomal miRNAs in neurological disorders [J]. Neural Regen Res, 2021, 16(12): 2359.
[13]Zhao H, Li Y, Chen L, et al. HucMSCs-derived miR-206-knockdown exosomes contribute to neuroprotection in sub-arachnoid hemorrhage induced early brain injury by targeting BDNF [J]. Neuroscience, 2019, 417: 11-23.
[14]Gao X, Xiong Y, Li Q, et al. Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage [J]. Cell Death Dis, 2020, 11(5): 363.
[15]Xiong L, Sun L, Zhang Y, et al. Exosomes from bone marrow mesenchymal stem cells can alleviate early brain injury after subarachnoid hemorrhage through miRNA129-5p-HMGB1 pathway [J]. Stem Cells Dev, 2020, 29(4): 212-221.
[16]Marbacher S, Grvter B, Sch?pf S, et al. Systematic review of in vivo animal models of subarachnoid hemorrhage: species, standard parameters, and outcomes [J]. Transl Stroke Res, 2019, 10(3): 250-258.
[17]Sugawara T, Ayer R, Jadhav V, et al. A new grading system evaluating bleeding scale in filament perforation subarach-noid hemorrhage rat model [J]. J Neurosci Methods, 2008, 167(2): 327-334.
[18]Jeong H, Cha BG, Kang D, et al. Ceria nanoparticles synthe-sized with aminocaproic acid for the treatment of subarach-noid hemorrhage [J]. Stroke, 2018, 49(12): 3030-3038.
[19]Zhang L, Guo K, Yin S, et al. RNA-Seq reveals underlying transcriptomic mechanisms of bone marrow-derived mesen-chymal stem cells in the regulation of microglia-mediated neuroinflammation after subarachnoid hemorrhage [J]. Stem Cells Dev, 2020, 29(9): 562-573.
[20]Li M, Wang Y, Wang W, et al. Recombinant human brainderived neurotrophic factor prevents neuronal apoptosis in a novel in vitro model of subarachnoid hemorrhage [J]. Neuropsychiatr Dis Treat, 2017, 13: 1013-1021.
[21]王跃飞，李明昌，邹长林，等. 血液溶解产物对原代培养的小鼠脑皮层神经元的影响[J]. 中国临床神经外科杂志，2016，21（11）：689-693.
[22]Nijboer CH, Kooijman E, van Velthoven CT, et al. Intranasal stem cell treatment as a novel therapy for subarach-noid hemorrhage [J]. Stem Cells Dev, 2018, 27(5): 313-325.
[23]Chen H, Chen L, Xie D, et al. Protective effects of transforming growth factor-β1 knockdown in human umbilical cord mesenchymal stem cells against subarachnoid hemorrhage in a rat model [J]. Cerebrovasc Dis, 2020, 49(1): 79-87.
[24]Liu Z, Wang B, Guo Q. MiR-26b-5p-modified hUB-MSCs derived exosomes attenuate early brain injury during sub-arachnoid hemorrhage via MAT2A-mediated the p38 MAPK/STAT3 signaling pathway [J]. Brain Res Bull, 2021, 175: 107-115.
[25]Han M, Cao Y, Guo X, et al. Mesenchymal stem cell-derived extracellular vesicles promote microglial M2 polarization after subarachnoid hemorrhage in rats and involve the AMPK/NF-κB signaling pathway [J]. Biomed Pharmacother, 2021, 133: 111048.
[26]Khalili MA, Sadeghian-Nodoushan F, Fesahat F, et al. Mesenchymal stem cells improved the ultrastructural morphology of cerebral tissues after subarachnoid hemorrhage in rats [J]. Exp Neurobiol, 2014, 23(1): 77-85.
相似文献/References:
[1]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(08):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[2]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[3]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[4]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[5]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(08):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[6]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[7]水 涛 郭再玉 综述 马廉亭 审校.蛛网膜下腔出血后脑血管痉挛的亚低温治疗进展[J].中国临床神经外科杂志,2016,(03):185.[doi:10.13798/j.issn.1009-153X.2016.03.021]
[8]赵建伍 于耀宇 余天垒 李延良 唐 铸 桂 铮 周 欣 姬文婕.黄芪甲苷对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(06):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
ZHAO Jian-wu,YU Yao-yu,YU Tian-lei,et al.Effects of Astragaloside Ⅳ on delayed cerebral vasospasm after subarachnoid hemorrhage[J].,2015,(08):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
[9]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(08):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[10]旷仁钊 综述 唐晓平 审校.蛛网膜下腔出血后脑血管痉挛药物治疗的研究进展[J].中国临床神经外科杂志,2015,(09):572.[doi:10.13798/j.issn.1009-153X.2015.09.024]